Log in

LON:ARIX - Arix Bioscience Share Price, Forecast & News

GBX 64
0.00 (0.00 %)
(As of 03/29/2020 07:41 AM ET)
Today's Range
62
Now: GBX 64
65.45
50-Day Range
60
MA: GBX 79.19
91
52-Week Range
72
Now: GBX 64
159
Volume375,429 shs
Average Volume65,433 shs
Market Capitalization£86.75 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Arix Bioscience plc, formerly known as Perceptive Bioscience Investments Limited, is a venture capital firm specializing in seed, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is based in London, United Kingdom with an additional office in New York, New York.
Read More

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-72901050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£-58,136,000.00
Cash FlowGBX 36.99 per share
Book ValueGBX 154.90 per share

Profitability

Miscellaneous

Employees14
Market Cap£86.75 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ARIX News and Ratings via Email

Sign-up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter.


Arix Bioscience (LON:ARIX) Frequently Asked Questions

How has Arix Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Arix Bioscience's stock was trading at GBX 77 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ARIX shares have decreased by 16.9% and is now trading at GBX 64. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Arix Bioscience?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Arix Bioscience.

What price target have analysts set for ARIX?

3 brokerages have issued 1-year price objectives for Arix Bioscience's shares. Their forecasts range from GBX 270 to GBX 270. On average, they expect Arix Bioscience's share price to reach GBX 270 in the next year. This suggests a possible upside of 321.9% from the stock's current price. View analysts' price targets for Arix Bioscience.

Has Arix Bioscience been receiving favorable news coverage?

Press coverage about ARIX stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Arix Bioscience earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the company's share price in the near future. View the latest news aboutArix Bioscience.

Who are some of Arix Bioscience's key competitors?

What other stocks do shareholders of Arix Bioscience own?

Who are Arix Bioscience's key executives?

Arix Bioscience's management team includes the following people:
  • Dr. Joseph Anderson, CEO & Co-Founder (Age 60)
  • Mr. James Hedley Rawlingson, Chief Financial Officer (Age 51)
  • Sir Christopher Thomas Evans, Consultant (Age 62)
  • Mr. Robert Lyne, COO, Gen. Counsel & Company Sec.
  • Ms. Charlotte Parry, Head of Investor Relations

What is Arix Bioscience's stock symbol?

Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX."

How do I buy shares of Arix Bioscience?

Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Arix Bioscience's stock price today?

One share of ARIX stock can currently be purchased for approximately GBX 64.

How big of a company is Arix Bioscience?

Arix Bioscience has a market capitalization of £86.75 million and generates £-58,136,000.00 in revenue each year. Arix Bioscience employs 14 workers across the globe. View additional information about Arix Bioscience.

What is Arix Bioscience's official website?

The official website for Arix Bioscience is http://arixbioscience.com/.

How can I contact Arix Bioscience?

Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050.


MarketBeat Community Rating for Arix Bioscience (LON ARIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  168
MarketBeat's community ratings are surveys of what our community members think about Arix Bioscience and other stocks. Vote "Outperform" if you believe ARIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Economic Bubble

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel